IN8bio says JCO publication shows INB-200 trial doubles progression-free survival in repeat-dose glioblastoma patientsPUBT·Jul 9 at 07:03 AMINAB-3.25%
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga_article·Jun 11 at 04:05 PMRDHL-2.47%INAB-3.25%
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | INAB Stock NewsStockTitan·Apr 3 at 07:00 AMBIB+1.68%SBIO+0.37%
